|
19 Nov 2019 |
Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants
|
|
19 Nov 2019 |
Zelluna Immunotherapy and Glycostem Therapeutics announce partnership to develop allogeneic TCR-NK therapies
|
|
19 Nov 2019 |
Idorsia enters into a collaboration with Antares for the development of a novel self-administered drug-device product for selatogrel
|
|
19 Nov 2019 |
Alkermes to Acquire Rodin Therapeutics
|
|
19 Nov 2019 |
Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-Related Cardio-Metabolic Diseases
|
|
16 Nov 2019 |
Promedior Enters Into Definitive Merger Agreement To Be Acquired By Roche
|
|
14 Nov 2019 |
Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies
|
|
14 Nov 2019 |
Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovascular and gynecological diseases
|
|
14 Nov 2019 |
Poised for Significant Growth and Profitability, BioMarin Shares Company Highlights During R&D Day on November 14th in New York
|
|
14 Nov 2019 |
Takeda Announces 12 New Molecular Entities with the Potential for 14 Launches in the Next Five Years at 2019 R&D Day
|
|
14 Nov 2019 |
Exicure and Allergan Enter Into Collaboration, Option and License Agreement to Discover and Develop SNA-based Treatments for Hair Loss Disorders
|
|
13 Nov 2019 |
Avidity Biosciences Completes $100 Million Series C Financing
|
|
13 Nov 2019 |
COI Pharmaceuticals Announces Acquisition of Calporta by Merck
|
|
12 Nov 2019 |
bluebird bio and Forty Seven Announce a Research Collaboration to Study an All Antibody Conditioning Regimen for Use in Combination with Autologous Lentiviral Vector Hematopoietic Stem Cell Gene Therapy
|
|
11 Nov 2019 |
Foamix and Menlo Therapeutics to Merge, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications
|
|
11 Nov 2019 |
UroGen Pharma Announces Exclusive License Agreement with Agenus Inc to Advance Treatment of Urinary Tract Cancers
|
|
09 Nov 2019 |
Akeso, Inc. Completed Series-D Private Financing for close to US$150 Million
|
|
09 Nov 2019 |
Ningbo Tai Kang Medical Technology Co., Ltd Announces Global Licensing Agreement With AstraZeneca
|
|
07 Nov 2019 |
Bayer invests USD 50 Million in eGenesis Series B financing round
|
|
07 Nov 2019 |
Novo Nordisk obtains exclusive worldwide licence to potential NASH candidate UD-014 from UBE Industries
|
|
07 Nov 2019 |
Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases
|
|
07 Nov 2019 |
Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364
|
|
07 Nov 2019 |
Alvotech and STADA Agree on Strategic Biosimilar Partnership
|
|
06 Nov 2019 |
Artios Pharma, MD Anderson and ShangPharma Announce In-Licensing Agreement for DNA Damage Response Inhibitor
|
|
06 Nov 2019 |
Seattle Genetics and BeiGene Announce Global License Agreement for Advanced Preclinical Product Candidate
|
